Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Accounts Payables (2016 - 2025)

Marimed has reported Accounts Payables over the past 15 years, most recently at $14.6 million for Q4 2025.

  • Quarterly Accounts Payables rose 10.59% to $14.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.6 million through Dec 2025, up 10.59% year-over-year, with the annual reading at $14.6 million for FY2025, 10.59% up from the prior year.
  • Accounts Payables was $14.6 million for Q4 2025 at Marimed, up from $11.2 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $14.6 million in Q4 2025 and troughed at $4.7 million in Q1 2023.
  • The 5-year median for Accounts Payables is $8.4 million (2022), against an average of $9.2 million.
  • Year-over-year, Accounts Payables crashed 43.87% in 2023 and then soared 119.85% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $5.1 million in 2021, then increased by 29.95% to $6.6 million in 2022, then soared by 35.84% to $9.0 million in 2023, then soared by 46.53% to $13.2 million in 2024, then grew by 10.59% to $14.6 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Accounts Payables are $14.6 million (Q4 2025), $11.2 million (Q3 2025), and $11.2 million (Q2 2025).